Insider · CIK 0001680628

Haddock Jason

Reports to the SEC for 3 companies · UTRECHT, P7

sec.gov

Transactions

Companies

Filings

CIK

0001680628

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.2K sh	—	—	0
2025-12-12	MRUSMerus N.V. · Share Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.7K sh	—	—	0
2025-05-22	MRUSMerus N.V. · Share Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,193
2024-05-07	MRUSMerus N.V. · Share Option (right to buy)A Award	Director	AAward	+17.7K sh	—	—	17,688
2023-02-16	Codiak BioSciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,750 sh	—	—	8,750
2023-02-16	Codiak BioSciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,750 sh	—	—	0
2022-06-17	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2022-06-17	Codiak BioSciences, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,500 sh	—	—	1,500
2022-02-16	Codiak BioSciences, Inc.Restricted Stock UnitsA Award	Director	AAward	+8,750 sh	—	—	8,750
2021-06-18	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-11-13	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,996 sh	—	—	7,996
2020-10-13	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-08-26	Codiak BioSciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	31,981
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	CFO	DDisposition to Issuer	−30.1K sh	$48.00	−$1.44M	56,026
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	CFO	DDisposition to Issuer	−56K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CFO	DDisposition to Issuer	−404K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CFO	DDisposition to Issuer	−105K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CFO	DDisposition to Issuer	−168K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	CFO	DDisposition to Issuer	−158K sh	—	—	0
2019-02-07	ARRAY BIOPHARMA INCM Exercise/Conversion	CFO	MExercise/Conversion	+85K sh	$3.77	+$320K	115,059
2019-02-07	ARRAY BIOPHARMA INCS Sale	CFO	SSale	−85K sh	$22.05	−$1.87M	30,059
2019-02-07	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	CFO	MExercise/Conversion	−85K sh	—	—	404,450
2019-02-06	ARRAY BIOPHARMA INCS Sale	CFO	SSale	−11.7K sh	$20.00	−$234K	30,059
2018-12-16	ARRAY BIOPHARMA INCM Exercise/Conversion	CFO	MExercise/Conversion	+11.4K sh	—	—	46,780
2018-12-16	ARRAY BIOPHARMA INCF Tax Payment	CFO	FTax Payment	−5,009 sh	$15.97	−$80K	41,771
2018-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	CFO	MExercise/Conversion	−4,387 sh	—	—	8,766
2018-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	CFO	MExercise/Conversion	−7,000 sh	—	—	21,000
2018-12-14	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	CFO	AAward	+26.3K sh	—	—	26,250
2018-12-14	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	CFO	AAward	+158K sh	—	—	157,500
2018-08-15	ARRAY BIOPHARMA INCS Sale	CFO	SSale	−20K sh	$13.92	−$278K	35,393
2018-07-30	ARRAY BIOPHARMA INCM Exercise/Conversion	CFO	MExercise/Conversion	+51.5K sh	$3.77	+$194K	80,393
2018-07-30	ARRAY BIOPHARMA INCS Sale	CFO	SSale	−25K sh	$14.87	−$372K	55,393
2018-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	CFO	MExercise/Conversion	−51.5K sh	—	—	489,450
2018-01-16	ARRAY BIOPHARMA INCM Exercise/Conversion	CFO	MExercise/Conversion	+14K sh	$3.77	+$52.9K	36,368
2018-01-16	ARRAY BIOPHARMA INCS Sale	CFO	SSale	−7,500 sh	$13.73	−$103K	28,868
2018-01-16	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	CFO	MExercise/Conversion	−14K sh	—	—	540,975
2017-12-16	ARRAY BIOPHARMA INCM Exercise/Conversion	CFO	MExercise/Conversion	+4,387 sh	—	—	24,387
2017-12-16	ARRAY BIOPHARMA INCF Tax Payment	CFO	FTax Payment	−2,044 sh	$10.92	−$22.3K	22,343
2017-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	CFO	MExercise/Conversion	−4,387 sh	—	—	13,163
2017-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	CFO	AAward	+28K sh	—	—	28,000
2017-12-16	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	CFO	AAward	+168K sh	—	—	168,000
2017-08-14	ARRAY BIOPHARMA INCM Exercise/Conversion	CFO	MExercise/Conversion	+20K sh	$3.77	+$75.4K	20,000
2017-08-14	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	CFO	MExercise/Conversion	−20K sh	—	—	555,000
2016-12-27	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	CFO	AAward	+17.6K sh	—	—	17,550
2016-12-27	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	CFO	AAward	+105K sh	—	—	105,302

Recent filings

Accepted (ET)
Dec 124
Haddock Jason0001193125-25-317958
SEC(opens sec.gov)
May 274
Haddock Jason0000950170-25-077386
SEC(opens sec.gov)
May 94
Haddock Jason0000950170-24-057138
SEC(opens sec.gov)
Feb 214
Haddock Jason0000899243-23-005692
SEC(opens sec.gov)
Jun 214
Haddock Jason0000899243-22-023407
SEC(opens sec.gov)
Feb 184
Haddock Jason0000899243-22-007006
SEC(opens sec.gov)
Jun 224
Haddock Jason0000899243-21-025389
SEC(opens sec.gov)
Nov 174
Haddock Jason0000899243-20-031325
SEC(opens sec.gov)
Oct 154
Haddock Jason0000899243-20-028422
SEC(opens sec.gov)
Jul 304
Haddock Jason0001209191-19-043779
SEC(opens sec.gov)
Feb 84
Haddock Jason0001562180-19-000861
SEC(opens sec.gov)

Companies

Address

C/O MERUS N.V. UPPSALALAAN 17

UTRECHT, P7, 3584 CT